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Abstract
Objective:  To  assess  the  effectiveness  of  an  educational  intervention  on  antibiotic  adherence
and patient-reported  resolution  of  symptoms.
Design:  A  controlled  experimental  study  with  systematic  assignment  to  groups.
Setting:  A  pharmacy  in  Murcia.  Participants  were  patients  who  came  to  the  pharmacy  with
a prescription  for  antibiotics.  Intervention  provided  information  on  treatment  characteristics
(duration,  dose  and  method  of  use)  and  correct  compliance.  A  control  group  received  routine
care. Main  variables  ‘‘treatment  adherence’’  and  ‘‘perceived  health’’  were  evaluated  one  week
after dispensation  by  telephone  interview.
Results:  A  total  of  126  patients  completed  the  study,  62  in  the  Control  Group  (CG)  and  64  in
the Intervention  Group  (IG).  There  were  no  differences  between  the  groups  in  baseline  char-
acteristics,  including  the  level  of  knowledge  before  the  intervention.  At  the  end  of  the  study,
treatment  adherence  in  the  CG  was  48.4%  (CI:  36.4--60.6),  compared  with  67.2%  (CI:  55.0--77.4)
in the  IG.  The  difference  of  18.8%  was  statistically  signiﬁcant  (p  =  0.033;  95%  CI  =  15.8--34.6).
Non-compliance  through  missing  more  than  one  dose  was  81.2%  in  the  CG  versus  38.1%  in  the
IG, which  is  a  statistically  signiﬁcant  difference  of  43.1%  (p  =  0.001;  95%  CI  =  16.4--63.1%).  No
signiﬁcant differences  were  found  in  patient-perceived  health.  Logistic  regression  showed  as
predictor of  adherence,  the  medication  knowledge  and  the  coincidence  between  duration  of
treatment indicated  by  physician  and  duration  of  treatment  written  in  the  prescription.
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Conclusions:  An  educational  intervention  during  antibiotic  dispensation  improves  treatment
adherence  versus  routine  care.
© 2013  Elsevier  Espan˜a,  S.L.U.  All  rights  reserved.
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Efecto  de  una  intervención  educativa  para  mejorar  la  adherencia  de  los  pacientes  al
tratamiento  antibiótico  durante  la  dispensación  en  una  farmacia  comunitaria
Resumen
Objetivo:  Evaluar  la  efectividad  de  la  intervención  educativa  en  la  adherencia  al  tratamiento
con antibióticos  y  en  la  evolución  de  los  síntomas  referidos  por  el  paciente.
Disen˜o: Estudio  experimental  controlado  con  asignación  sistemática.  Emplazamiento:  farmacia
comunitaria  en  Murcia.  Participantes:  pacientes  que  acudieron  a  la  farmacia  con  una  receta  de
antibiótico.
Intervención:  Aportar  información  sobre  las  características  del  tratamiento  (duración,  pauta
y forma  de  utilización)  y  la  correcta  adherencia.  En  el  grupo  Control  se  procedió  a  una  venta
habitual.  Mediciones  principales:  se  evaluaron  la  «adherencia  al  tratamiento» y la  «percepción
de salud» a  la  semana  de  la  dispensación  mediante  entrevista  telefónica.
Resultados:  Finalizaron  el  estudio  126  pacientes:  62  en  el  Grupo  Control  (GC)  y  64  en  el  Grupo
Intervención  (GI).  No  hubo  diferencias  entre  grupos  en  las  características  basales,  incluido
el nivel  de  conocimientos  previo  a  la  intervención.  Tras  la  intervención,  la  adherencia  al
tratamiento  en  el  GC  fue  del  48,4%  (IC  95%:  36,4-60,6)  frente  al  67,2%  (IC  95%:  55,0-77,4)
del GI,  siendo  esta  diferencia  del  18,8%  (p  =  0,033;  IC  95%:  15,8-34,6;).  La  falta  de  adherencia
fue de  más  de  una  toma  en  el  81,2%  GC  vs  el  38,1%  GI,  diferencia  del  43,1%  (p  =  0,001;  IC  95%:
16,4-63,1%).  En  la  percepción  de  salud  del  paciente  no  se  encontraron  diferencias.  La  regresión
logística mostró  como  predictor  de  adherencia  el  conocimiento  de  la  medicación  y  la  coinciden-
cia entre  la  duración  del  tratamiento  indicado  por  el  médico  y  la  duración  del  envase  prescrito
en la  receta.
Conclusiones:  Una  intervención  educativa  durante  la  dispensación  del  antibiótico  mejora  la
adherencia  al  tratamiento  frente  a  una  atención  habitual.
© 2013  Elsevier  Espan˜a,  S.L.U.  Todos  los  derechos  reservados.
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ack  of  treatment  adherence  and  self-medication  are  two  of
he  biggest  problems  in  antibiotic  misuse  among  patients.1--3
dherence  has  been  specially  studied  in  chronic  but  not
n  acute  diseases  such  as  infectious  diseases.4 A  meta-
nalysis  found  that  37.8%  of  patients  forget  to  take  a dose
f  antibiotic.5 The  rate  of  adherence  in  this  therapy  in  our
ountry  is  not  well  known.  Few  studies  have  examined  the
ompliance  with  antibiotic  regimens,  with  ﬁgures  between
0  and  60%.6,7 The  42%  found  in  the  Pan  European  Survey  of
atients  was  higher  than  values  found  in  Italy  (34%),  Belgium
18%),  France  (16%)  and  Britain  (9%).8
Unlike  drugs  that  only  affect  individual  patients,  mis-
sed  antibiotics  add  the  global  risk  of  bacterial  resistance,
hich  jeopardizes  their  effectiveness.9 In  Spain  resistance
ates  are  particularly  high  and  their  consequences  are
erious:  resistant  bacterial  infections  are  associated  with
ncreased  morbidity,  mortality,  health  demands,  hospitaliza-
ion,  medical  expense  and  impairment  of  the  effectiveness
f  treatment  of  future  patients.10,11The  WHO  Strategy  for  Containment  of  Antimicrobial
esistance  encourages  prescribers  and  dispensers  to  educate
atients  on  the  proper  use  of  antibiotics  and  the  importance
f  completing  the  prescribed  treatment.12
O
A
cResults  of  intervention  studies  in  community  pharmacy
bout  improving  treatment  adherence  are  variable.  A  sys-
ematic  revision  conducted  in  2005  concluded  that  it  is
mpossible  to  identify  an  overall  successful  adherence-
mproving  strategy  performed  by  pharmacists  and  that
ore  well-designed  and  well-conducted  studies  need  to  be
erformed.13
In  our  country  there  are  few  studies  that  address  this
uestion  from  the  sphere  of  pharmacy;  they  are  of  local
cope  or  with  design  problems,  they  provide  written  infor-
ation  and  their  results  are  non-signiﬁcant.14,15 For  this
eason,  we  considered  it  important  to  conduct  a  study  to
valuate  the  beneﬁt  of  an  oral  educational  intervention,
n  terms  of  increased  treatment  adherence  and  symptom
mprovement  or  resolution,  vs.  ‘‘routine  pharmaceutical
are’’.
ethods
tudy  populationur  study,  the  ICAB  (Interventión  in  Compliance  of
ntiBiotics), is  a  community  pharmacy-based,  open-label,
ontrolled  trial  to  improve  medication  adherence  in
t  ant
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tThe  effect  of  an  educational  intervention  to  improve  patien
antibiotic  users.  The  ﬁeldwork  took  place  at  a  community
pharmacy  in  Murcia,  and  it  covered  a  period  of  eight  months
(January--August  2010).
The  study  had  an  experimental  design  with  a  control
group  (CG),  which  followed  routine  dispensing  practice,  and
an  intervention  group  (IG),  which  followed  an  antibiotic  dis-
pensing  protocol,  as  described  below.
Patients  were  eligible  for  inclusion  if  they  were  aged  18
years  or  older  and  came  to  the  pharmacy  during  the  study
period  to  collect  oral  antibiotics  prescribed  for  themselves
or  someone  they  were  looking  after.
Study  design
All  adult  patients  who  came  to  the  pharmacy  with  a  pre-
scription  for  an  antibiotic  were  selected  until  the  required
sample  size  was  attained.  The  patients  were  invited  to  sign
the  consent  form  and  only  those  who  gave  their  consent
entered  the  study.
Assignment  to  groups  was  carried  out  systematically.We
randomized  if  the  ﬁrst  patient  entered  the  intervention
group  or  control  group  through  a  coin  toss,  and  thereafter
patients  were  assigned  consecutively  to  the  IG  or  the  CG.
Interventions
The  patients  or  carers  in  the  IG  followed  an  antibiotic  dis-
pensing  protocol  drawn  up  by  the  head  pharmacist.  For  this,
a  Dispensing  Guideline  that  contained  the  most  important
pharmacological  data  on  each  antibiotic,  using  two  books
for  reference,16,17 was  written.  The  intervention  focused  on
providing  individualized  verbal  information  to  the  patient
or  carer  about  treatment  characteristics,  duration,  dosage
regime  and  how  to  use  the  antibiotic.  Written  information
was  not  provided.  The  talk  took  place  in  an  area  set  apart
from  the  counter,  and  lasted  about  20  min.
The  subject’s  degree  of  knowledge  of  the  antibiotic  was
evaluated  before  the  intervention  by  means  of  the  validated
questionnaire  by  Garcia  et  al.18
If  the  antibiotic  was  being  dispensed  for  the  ﬁrst  time,
the  pharmacist  checked  if  there  were  criteria  for  not
dispensing  it  (clinically  relevant  interactions  or  contraindi-
cations,  in  which  case  the  patient  was  referred  to  the
physician),  and  the  patient  understood  the  process  of  using
the  antibiotic,  through  a  knowledge  test.  If  it  was  not  the
ﬁrst  time,  treatment  effectiveness  was  assessed,  checking
whether  the  antibiotic  was  being  used  correctly  and  safely
through  the  same  knowledge  test.  In  all  cases,  if  a  lack
of  knowledge  was  detected,  personalized  information  was
provided  to  make  up  for  it.
In  the  CG,  any  questions  asked  by  the  patient  or  carer
at  their  initiative  was  answered,  and  the  antibiotic  was  not
dispensed  if  there  were  any  criteria  for  not  doing  so.
(
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ariables
ociodemographic  and  clinical  variables  were  registered
n  all  cases  (Table  1).  We  measured  the  coincidence
etween  duration  of  treatment  indicated  by  physician  orally
nd  duration  of  drugs  container  written  in  the  prescrip-
ion.
To  determine  the  effectiveness  of  the  intervention,  a
elephone  interview  was  carried  out  seven  days  after  the
ispensation.  In  case  of  longer  duration  treatments,  the
all  was  delayed  until  the  end  date  of  treatment.  The
nterviewer  was  blinded  to  the  group  allocation  of  the
atient.
The  study  architecture  is  summarized  in  the  ﬂowchart.
The  adherence  to  antibiotic  treatment  was  evaluated  by
 combination  of  the  Morisky--Green  test  and  a  self-reported
ill  Count.19,20 Patients  were  considered  compliant  if  they
ere  categorized  as  such  in  both  evaluations,  and  non-
ompliant  if  they  were  found  to  be  non-compliant  in  either
f  the  two  tests.  Patients  who  took  liquid  dosage  forms  were
nly  evaluated  using  the  Morisky--Green  test.
Non-treatment-compliant  patients  were  categorized  as
ild  if  a  single  dose  was  missed,  and  moderate,  if  more
han  one  dose  was  missed.
The  subject-perceived  health  was  evaluated  by  the  ques-
ion:  How  did  you  get  on  with  the  treatment?  The  answers
ere  classiﬁed  as  cured,  improved,  the  same,  or  worse.
tatistical  analysis
he  required  sample  size  was  calculated  in  order  to  make  a
omparison  of  two  proportions  in  independent  groups,  with
n  80%  power  to  detect  a  difference  of  25%  in  adherence,
ssuming  a  compliance  of  50%  in  the  CG,26 using  a  two-tailed
tatistical  test  and  an  alpha  risk  of  0.05.  At  least  58  patients
ere  required  per  group.  Considering  a  potential  loss  to
ollow-up  and  dropout  rate  of  20%,  70  patients  were  needed
o  be  enrolled  in  each  group.
The  statistical  package  SPSS  v.18.0  was  used  for  the
ata  analysis.  Qualitative  variables  were  expressed  as  per-
entages  and  quantitative  variables  as  mean  and  standard
eviation  (SD).  Conﬁdence  intervals  (CI)  were  calculated
t  95%.  The  Pearson  Chi-square  test  was  used  to  compare
ualitative  variables.
To  assess  potential  factors  associated  with  treatment
dherence,  a  binary  logistic  regression  model  was  drawn  up
sing  the  backward  stepwise  method  (likelihood  ratio).
The  logistic  regression  model  was  used  to  analyze
he  association  of  the  dichotomous  dependent  variable
adherence  to  antibiotic  treatment)  and  a  set  of  indepen-
ent  variables.  The  model  included  as  predictors  variables
hat  were  statistically  signiﬁcant  in  the  bivariate  analysis
p  <  0.1).
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 Patient progress during the study 
Baseline interview and knowledge test
Final interview and adherence test (n = 62) Final interview and a
Participation refused (n = 2)
First dispensing 
(n = 54)
First dispensing 
(n = 58) 
Repeat 
dispensing (n = 4)
Intervention grou
dispensing (
Patients lost to follow
be contacted by te
Patients lost to follow-up who could not 
be contacted by telephone (n = 8)
Participation agreed (n = 138)
Control group / routine care 
(n = 70)
Information about the study and invitation to participate (n =
Patients requesting an antibiotic
eneral  outline  of  the  study:
esults
f  the  138  patients  initially  included,  12  were  lost  to  follow-
p  because  they  could  not  be  contacted  by  telephone.  There
ere  no  statistically  signiﬁcant  differences,  so  the  126  valid
ases  (62  CG  vs.  64  IG)  were  analyzed.
The  groups  were  comparable  by  the  sociodemographic
nd  clinical  variables  (Table  1).  In  the  CG,  the  mean  age
as  44.8  years  (SD  =  17.7)  and  in  the  IG  it  was  44.5  years
SD  =  18.2).  There  was  a  majority  of  women  in  both  groups
69.4%  and  65.6%  in  the  CG  and  IG,  respectively).  No  sig-
iﬁcant  differences  in  the  degree  of  knowledge  were  found
etween  the  groups.
Adherence  to  antibiotic  treatment  was  48.4%  (CI:
6.4--60.6)  in  the  CG  and  67.2%  (CI:  55.0--77.4)  in  the  IG,
ith  a  difference  of  18.8%  (95%  CI  =  15.8--34.6;  p  =  0.033).
oderate  non-compliance  (more  than  one  dose  intake  miss-
ng)  was  observed  in  81.2%  of  patients  in  the  CG  and  in  38.1%
n  the  IG,  with  a  difference  of  43.1%  (95%  CI  =  16.4--63.1%;
 =  0.001).
There  was  no  signiﬁcant  difference  in  the  health  percep-
ion,  although  it  was  higher  in  the  IG,  with  reports  of  being
‘totally  cured’’  in  54.7%  (95%  IC  =  42.6--66.3)  in  the  IG  and
n  46.8%  (95%  IC  =  34.9--59.0)  in  the  CG  (p  =  0.297).Results  of  the  bivariate  analysis  are  presented  in  Table  2.
ariables  with  a  p  <  0.1  were  selected  to  be  included  in  the
egression  model.  The  logistic  regression  analysis  conﬁrmed
 group  effect  (OR  2.23;  95%  CI  =  1.01--4.93;  p  =  0.047).  The
b
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nce test (n = 64)
Repeat 
dispensing 
(n = 10)
rmed 
)
ho could not 
ne (n = 4)
ariables  that  positively  inﬂuenced  adherence  were  the
nowledge  of  the  antibiotic  treatment  before  the  interven-
ion  (OR  3.06;  95%  CI  =  1.34--6.99)  and  coincidence  between
uration  of  treatment  indicated  by  physician  and  duration
f  drugs  container  written  in  the  prescription  (OR  2.84;  95%
I  =  1.16--6.99).  The  use  of  beta-lactams  has  a  negative  inﬂu-
nce  (OR  0.32;  95%  CI  =  0.14--0.72).  This  model  used  99.2%
f  the  study  sample.  The  model  goodness-of-ﬁt  was  good  as
ssessed  by  the  Hosmer--Lemeshow  test  (2 4.7;  p  =  0.786).
iscussion
he  study  results  show  that  implementing  an  educational
ntervention  when  patients  come  to  a  pharmacy  to  collect
ntibiotics  that  they  have  been  prescribed,  increases  adher-
nce  to  the  treatment.  However,  this  does  not  mean  that  the
atient  will  feel  cured  at  the  end  of  the  treatment  course.
he  educational  intervention  in  this  study  was  effective,
ith  an  18.8%  difference  in  compliance  between  the  CG  and
he  IG.
A  meta-analysis  and  a  Cochrane  review  found  interven-
ions  carried  out  by  health  professionals  (physicians,  nurses,
harmacists)  to  be  effective  on  treatment  adherence,21,22ut  pharmaceutical  interventions  found  mixed  results13,23--25
nd  it  is  difﬁcult  to  identify  an  overall  successful
trategy  improving  adherence  --  performed  by  pharma-
ists.  In  our  country,  there  have  been  positive  results
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Table  1  Comparison  of  sociodemographic  and  clinical  variables  between  control  group  and  intervention  group.
Variables  CG  (n  =  62)  IG  (n  =  64)  p-Value
Mean  age  (SD)  44.8  (17.7)  44.5  (18.2)  0.85
Age range  n  (%)
<18  years  2  (3.2%)  1  (1.6%) 0.68
18--44 28  (45.2%)  34  (53.1%)
45--64 24  (38.7%)  21  (32.8%)
65--74 4  (6.5%)  3  (4.7%)
>75 4  (6.5%)  5  (7.8%)
Gender n  (%)
Male  19  (30.6%) 22  (34.4%) 0.66
Female 43  (69.4%) 42  (65.6%)
User n  (%)
Own  use  52  (83.9%)  50  (78.1%) 0.41
Carer 10  (16.1%)  14  (21.9%)
Country of  origin  n  (%)
Foreign  country  7  (11.3%)  2  (3.1%) 0.07
Spain 55  (88.7%)  62  (96.9%)
Educational level  n  (%)
University  30  (48.4%) 44  (68.8%) 0.12
Secondary  school 18  (29.0%) 13  (20.3%)
Primary school 12  (19.4%) 6  (9.4%)
No schooling 2  (3.2%) 1  (1.6%)
Profession n  (%)
Student  10  (16.1%)  9  (14.1%) 0.14
Managerial/business  3  (4.8%)  3  (4.7%)
University jobs/civil  servants  18  (29%)  30  (46.9%)
Administrative/sales  9  (14.5%)  12  (18.8%)
Labour 6  (9.7%)  4  (6.3%)
Housewife/pensioner/unemployed  16  (25.8%)  6  (9.4%)
Site of  infection  n  (%)
Respiratory  26  (41.9%)  29  (45.3%) 0.46
Dental 22  (35.5%)  15  (23.4%)
Genitourinary  9  (14.5%)  12  (18.8%)
Others 5  (8.1%)  8  (12.5%)
Type of  antibiotic  n  (%)
Betalactamic  34  (54.8%)  31  (48.4%) 0.83
Macrolide  13  (21%)  14  (21.9%)
Fluoroquinolone  5  (8.1%)  8  (12.5%)
Others 10  (16.1%)  11  (17.2%)
Time using  antibiotic  n  (%)
First  dispensing  58  (93.5%)  54  (84.4%) 0.10
Repeat dispensing  4  (6.5%)  10  (15.6%)
Match durationa
Yes  44  (71%)  49  (77.8%)  0.38
Knows the  name  of  the  drugb
Yes 29  (46.8%) 37  (57.8%)  0.21
Number of  medicationsc
None  11  (7.7%)  16  (25.4%) 0.16
Monotherapy  15  (24.2%)  22  (34.9%)
Complex therapyd 31  (50%)  19  (30.2%)
Polymedicatede 5  (8.1%)  6  (9.5%)
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Table  1  (Continued)
Variables  CG  (n  =  62)  IG  (n  =  64)  p-Value
Concerned  about  health  problem  n  (%)
Quite  concerned  14  (22.6%)  24  (37.5%) 0.19
Normal level  17  (27.4%)  15  (23.4%)
Fairly unconcerned  31  (50%)  25  (39.1%)
Level of  knowledge  of  antibiotic  treatment
No knowledge 26  (41.9%)  33  (51.6%) 0.58
Insufﬁcient  5  (8.1%) 3  (4.7%)
Sufﬁcient  27  (43.5%) 26  (40.6%)
Optimum 4  (6.5%)  2  (3.1%)
Treatment  adherence
Yes  30  (48.4%)  43  (67.2%)  0.033
Level of  non-adherence
Mild  6  (18.8%)  13  (61.9%) 0.001
Moderatef 26  (81.2%)  8  (38.1%)
Patient-perception  of  health
Worse  2  (3.2%)  0.0% 0.30
Same 6  (9.7%)  9  (14.1%)
Improved 25  (40.3%)  20  (31.3%)
Cured 29  (46.8%)  35  (54.7%)
SD, standard deviation.
a Match between duration of treatment indicated and prescribed.
b The patient knows the name of the drug.
c Number of medications the patient is taking excluding the antibiotic.
d 2--4 medications.
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ae 5 or more medications.
f Missing more than one dose.
ollowing  the  intervention  of  hospital  pharmacists  in
atients  with  other  pathologies,  albeit  with  a  small  sam-
le  size26.  In  a  community  pharmacy,  Machuca  et  al.
chieved  a  14%  increase  in  the  antibiotics  adherence.14
ndres  et  al.  also  improved  adherence,  although  the  differ-
nces  were  not  statistically  signiﬁcant.15 The  intervention
n  these  studies  was  done  with  written  information,  and
heir  results  were  not  strong.  The  results  of  our  study
rovide  valuable  information  about  the  effectiveness  of
ral  interventions  on  the  treatment  adherence  in  the  com-
unity  pharmacies,  which  are  close  and  accessible  to
he  patient,  and  should  be  used  to  actively  work  with
ther  health  professionals  in  the  appropriate  use  of  antibi-
tics.
The  adherence  in  the  IG  was  higher  than  average  antibi-
tic  therapy  adherence  reported  in  Spain  by  Gil  et  al.,
lthough  it  is  very  similar  to  that  found  by  other  authors.6,19
his  difference  may  be  related  to  the  measuring  method,  as
il  et  al.  used  the  technique  of  pill  counts,  while  the  other
wo  used  the  telephone  interview.  Factors  that  were  not
valuated  and  that  can  inﬂuence  adherence  are  the  dura-
ion  of  the  treatments  and  the  level  of  education  of  the
tudy  population.
Our  results  are  lower  than  those  found  in  a  meta-
nalysis  conducted  internationally,5 and  the  difference  may
8e  related  to  the  high  rate  of  resistance  in  our  country. It
s  difﬁcult  to  maintain  the  effectiveness  of  adherence  inter-
entions  over  time,  and  this  can  explain  the  better  results
n  acute  diseases.
m
H
t
tNo  signiﬁcant  differences  were  found  between  groups
ith  regard  to  patient-perceived  health.  This  may  be  due  to
he  fact  that  the  infectious  process  is  self-limiting  in  most
ases  and  resolves  without  intervention  in  a  short  time.  Dif-
erent  studies  show  that  there  is  a  relationship  between
ealth  as  perceived  by  patients  and  their  adherence  to
reatment.19,27 It  therefore  seems  important  to  analyze  this
ariable.  However,  we  must  bear  in  mind  that  we  mea-
ured  the  perceived  health  through  a single  direct  question
o  the  patient,  so  the  results  need  to  be  interpreted  with
aution.
Patients  frequently  report  discontinuing  antibiotic  ther-
py  when  they  begin  to  feel  better  or  when  adverse  events
ccur.28 This  might  be  the  main  cause  of  the  existence  of
ntibiotics  at  home29 and  of  self-medication,  in  few  cases
esponsible  for  the  emergence  of  resistance.8,29
Logistic  regression  showed  an  association  between
dherence  and  the  coincidence  between  the  duration  of
reatment  orally  indicated  by  the  physician  and  the  duration
f  treatment  written  on  the  prescription.  The  mismatch
etween  the  duration  of  antibiotic  treatment  and  the
ormat  in  which  drugs  are  manufactured  sometimes  makes
ore  than  one  container  necessary,  and  therefore  more
han  one  prescription  to  end  the  treatment.  This  could  be
 barrier  for  patients  to  successfully  complete  their  treat-
ent.  In  August  2012,  the  Spanish  Agency  for  Medicines  and
ealth  Products  issued  a  Resolution  on  matching  therapeu-
ic  drug  formats  (J01  and  J02  group),  urging  manufacturers
o  adapt  to  proper  formats  for  these  treatments.30
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Table  2  Bivariate  analysis  of  individuals  with  good  adherence  and  binary  logistic  regression  for  the  variable:  treatment
adherence.
Variables  OR  CI95%  p-Value*
Group  to  which  the  patient
CG/IG  2.18  1.06--4.49  0.025
Mean age  (SD)  1.01  0.99--1.03  0.24
Age range
<18  years  (referent)  0.68
18--44 0.42  0.04--4.27  0.46
45--64 0.40  0.04--4.10  0.44
65--74 1.33  0.06--31.12  0.86
>75 0.78 0.06--10.86  0.85
Gender
Male/female  1.04  0.49--2.21  0.54
User
Own use/carer  1.02  0.41--2.51  0.58
Country of  origin
Spain/foreign  country 1.49  0.36--6.26  0.43
Educational  level
Primary  school  (referent)  0.99
Secondary school  1.04  0.349--3.18  0.957
University 1.04  0.39--2.77  0.94
Profession
Housewife/pensioner/unemployed  (referent)  0.39
Labour 1.04  0.23--4.77  0.96
Administrative/sales  0.63  0.19--2.10  0.45
University jobs/civil  servants  1.52  0.53--4.34  0.43
Managerial/business  0.69  0.11--4.24  0.69
Student 0.50  0.15--1.75  0.28
Site of  infection
Others  (referent) 0.37
Respiratory 2.59 0.75--8.98  0.13
Genitourinary  3.20  0.76--13.50  0.11
Dental 1.88 0.52--6.85  0.34
Type of  antibiotic
Betalactamic  (1  =  yes)  0.36  0.17--0.75  0.006
Macrolide (1  =  yes)  4.14  1.45--11.81  0.004
Fluoroquinolone  (1  =  yes)  1.72  0.50--5.92  0.29
Time using  antibiotic
First  dispensation/repeat  dispensation  0.81  0.27--2.39  0.45
Match durationa
(1  =  yes)  3.03  1.32--6.97  0.007
Knows the  name  of  the  drugb
(1  =  yes)  0.97  0.48--1.97  0.54
Number of  medicationsc
None  (referent)  0.067
Monotherapy  0.69  0.25--1.92  0.47
Complex therapy  (2--4) 0.43  0.16--1.13  0.086
Polymedicated  (5  or  more) 5.00 0.55--45.39  0.15
Concerned  about  health  problem
Quite  concerned  (referent)  0.086
Normal level  of  concern  0.37  0.15--0.92  0.029
Fairly unconcerned  0.58  0.25--1.37  0.22
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Table  2  (Continued)
Variables  OR  CI95%  p-Value*
Level  of  knowledged
(1  =  known)  2.17  1.05--4.48  0.027
Patient-perception  of  health
Worse  (referent)  0.69
Same 1.44  0.64--6.09  0.39
Improved 0.68  0.22--2.10  0.50
Cured 0.78 0.05--12.99 0.86
Binary logistic  regression  for  the  variable:  treatment  adherence
Level of  knowledge  (1  =  known) 3.06 1.34--6.99 0.008
Betalactamic  (1  =  yes) 0.32 0.14--0.72 0.006
Match  duration  (1  =  yes)  2.84  1.16--6.98  0.023
Group to  which  the  patient  (1  =  IG)  2.23  1.01--4.94  0.047
Constant 0.47  0.16
CI, conﬁdence interval.
* p-value <0.1 is taken for the multivariable analysis.
a Match between duration of treatment indicated and prescribed.
b The patient knows the name of the drug.
c Number of medications the patient is taking excluding the antibiotic.
d Level of knowledge of antibiotic treatment is regrouped into two categories, ‘‘known’’ (No knowledge and Insufﬁcient Knowledge)
and ‘‘not known’’ (Sufﬁcient Knowledge and Optimum Knowledge) for the bivariate analysis.
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rLogistic  regression  also  showed  that  medication  knowl-
dge  is  correlated  with  medication  adherence.  This  ﬁnding
s  according  to  a  recent  publication.31 Therefore  improve-
ent  in  the  patient’s  knowledge  would  bear  a  positive  effect
n  adherence,  and  patient  education  in  the  proposed  dis-
ensing  protocol  is  considered  to  be  an  implicit  strategy
or  improving  compliance.  Pharmacists  should  be  encour-
ged  to  play  a  proactive  role  in  large-scale  health  education
rogrammes.
We  evaluated  patients’  baseline  knowledge  with  a  vali-
ated  questionnaire  -- this  is  a  strong  point  of  our  study,  as
t  is  the  ﬁrst  validated  questionnaire  to  speciﬁcally  assess
nowledge  of  patient  medication.20
The  study  has  the  limitations  inherent  to  using  differ-
nt  indirect  tests,  which  tend  to  overestimate  adherence,
lthough  the  use  of  two  different  methods  can  reduce  the
ias.  A  contamination  effect  could  have  occurred  consider-
ng  that  both  groups  have  antibiotics  dispensed  from  the
ame  site,  and  the  intervention  effect  could  have  been
ncreased.  The  study  was  conducted  in  a  local  setting,  so
he  results  cannot  be  extrapolated  to  wider  settings.  The
atient  allocation  was  not  randomized,  and  this  can  be  a
esign  of  weakness.  For  future  studies  it  would  be  advis-
ble  to  use  a  randomized  clinical  trial  design,  in  order  to
liminate  this  possible  bias.
In  conclusion,  pharmaceutical  intervention  increased
ntibiotic  adherence  in  this  community  pharmacy.  The
esults  suggest  that  knowledge  is  an  important  factor  asso-
iated  to  adherence,  and  that  an  intervention  aimed  at
ncreasing  it  may  improve  adherence.  Thereby,  this  report
lso  reinforces  the  pharmacists’  role  in  improving  the  health
are  system  and  they  should  be  strengthened  as  educators
n  the  rational  use  of  medicines.  It  is  necessary  to  conduct
ulticenter  studies  to  support  this  thesis,  to  verify  that  themplementation  of  these  services  in  the  pharmacy  is,  not
nly  effective,  but  also  feasible  and  compatible  with  the
est  of  the  activities.
What is known on this topic?
•  Lack  of  treatment  adherence  and  self-medication
are  two  of  the  biggest  problems  in  antibiotic  misuse
among  patients.
•  The  rate  of  adherence  in  antibiotic  therapy  in  our
country  is  not  well  known.
•  Intervention  studies  in  community  pharmacy  about
improving  adherence  to  treatment  have  obtained
different  results.
What does this study contribute to  the
literature?
•  The  research  results  indicate  that  the  contribution  of
personalized  information  orally  during  the  dispensing
could  increase  adherence  to  treatment.
•  Pharmacists  can  improve  adherence  to  treatment
with  antibiotics,  so  it  will  be  more  effective  treat-
ments  and  could  limit  the  emergence  of  antibiotic
resistance.
•  The  community  pharmacy  is  a  healthcare  area
close  and  accessible  to  the  patient,  and  should  be
exploited  to  actively  work  with  other  health  profes-
sionals  in  the  appropriate  use  of  antibiotics.
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